The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/dm/volume-2017/3160426/figures/3160426.fig.001a.svgz" name="3160426.fig.001a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>The total average peptide spectrum of MPE in training set</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/dm/volume-2017/3160426/figures/3160426.fig.001b.svgz" name="3160426.fig.001b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>The total average peptide spectrum of TPE in training set</td></tr></table>

<div>The total average peptide spectra of the training set displayed by ClinProTools software.</div>

Disease Markers

fig1

Figure 1

Figure 1: The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry 

Figure 1 | The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry 